Impact of original, B.1.1.7, and B.1.351/P.1 SARS-CoV-2 lineages on vaccine effectiveness of two doses of COVID-19 mRNA vaccines: Results from a nationwide case-control study in France

• Main Authors: Tiffany Charmet (Author), Laura Schaeffer (Author), Rebecca Grant (Author), Simon Galmiche (Author), Olivia Chény (Author), Cassandre Von Platen (Author), Alexandra Maurizot (Author), Alexandra Rogoff (Author), Faïza Omar (Author), Christophe David (Author), Alexandra Septfons (Author), Simon Cauchemez (Author), Alexandre Gaymard (Author), Bruno Lina (Author), Louise H Lefrancois (Author), Vincent Enouf (Author), Sylvie van der Werf (Author), Alexandra Mailles (Author), Daniel Levy-Bruhl (Author), Fabrice Carrat (Author), Arnaud Fontanet (Author)
• Format: Book
• Published: Elsevier, 2021-09-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: We aimed to assess the effectiveness of two doses of mRNA COVID-19 vaccines against COVID-19 with the original virus and other lineages circulating in France. Methods: In this nationwide case-control study, cases were SARS-CoV-2 infected adults with onset of symptoms between 14 February...